Does COVID-19 make the firms' performance worse? Evidence from the Chinese listed companies

被引:24
|
作者
Zhang, Dongyang [1 ]
Zheng, Wenping [2 ]
机构
[1] Capital Univ Econ & Business, Beijing, Peoples R China
[2] Univ Int Business & Econ, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
COVID-19; Operation performance; Environmental tax;
D O I
10.1016/j.eap.2022.03.001
中图分类号
F [经济];
学科分类号
02 ;
摘要
The influence of pandemics is still a black box, and the mechanism is attracting the attention of policymakers and scholars to guide the policy design in the aftermath of Covid-19 pandemics. This paper takes an in-depth look at the performance impact of pandemics from the perspective of operation, which is essential in a comprehensive evaluation of the economic effects of pandemics. With the help of novel quarterly data of Chinese listed firms from 2019 Q1 to 2021 Q2, we find that the Covid-19 decreases the sale-related profitability. For the mechanism, this paper finds that the pandemics make the operation longer, increase the cost, and reduce the potential cash flows. In addition, the environmental tax can significantly weaken the adverse shocks. The policy implication is that the sale boosting or consumption stimulus is vital in economic recovery, and the governments should efficiently use the positive effect of environmental tax. (c) 2022 Economic Society of Australia, Queensland. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:560 / 570
页数:11
相关论文
共 50 条
  • [1] The impact of COVID-19 on firm innovation: Evidence from Chinese listed companies
    Jin, Xin
    Zhang, Min
    Sun, Guanghua
    Cui, Lixin
    FINANCE RESEARCH LETTERS, 2022, 45
  • [2] COVID-19 Shock and Interest Expense Stickiness: Evidence from Chinese Listed Firms
    Wang, Rui
    Wang, Haomin
    Chen, Yi
    EMERGING MARKETS FINANCE AND TRADE, 2023, 59 (08) : 2356 - 2369
  • [3] Does asthma make COVID-19 worse?
    Hegde, Samarth
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (6) : 352 - 352
  • [4] Does asthma make COVID-19 worse?
    Samarth Hegde
    Nature Reviews Immunology, 2020, 20 : 352 - 352
  • [5] Impact of COVID-19 on family business performance: evidence from listed companies in Germany
    Eckey, Markus
    Memmel, Sebastian
    JOURNAL OF FAMILY BUSINESS MANAGEMENT, 2023, 13 (03) : 780 - 797
  • [6] COVID-19, financing constraints, and performance of listed tourism companies: Evidence from China
    Chen, Dan
    Tang, Yufei
    Zhang, Yuan
    Sun, Jingyu
    FINANCE RESEARCH LETTERS, 2024, 65
  • [7] Covid-19 crisis and corporate cash dividend policies: evidence from Chinese listed companies
    Xu, Xixiong
    Lin, Cuiliang
    Yan, Youliang
    APPLIED ECONOMICS LETTERS, 2023, 30 (02) : 178 - 184
  • [8] COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms
    Jie, Jiang
    Hou, Jack
    Cangyu, Wang
    HaiYue, Liu
    JOURNAL OF ASIAN ECONOMICS, 2021, 75
  • [9] COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility
    Sun, Yunpeng
    Li, Ying
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [10] Does hereditary angioedema make COVID-19 worse?
    Xu, Yingyang
    Liu, Shuang
    Zhang, Yan
    Zhi, Yuxiang
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (09):